Journal article icon

Journal article

99mTc-interleukin-2 scintigraphy in normal subjects and in patients with autoimmune thyroid diseases: a feasibility study.

Abstract:

PURPOSE: Radiolabelled interleukin-2 is a radiopharmaceutical used for the study of chronic inflammatory processes. (123)I-labelled interleukin-2 has successfully been used in a large number of patients affected by several immune-mediated diseases. (123)I, however, is expensive and not readily available. We have, therefore, developed a method for labelling interleukin-2 with (99m)Tc to high specific activity based on the use of an N(3)S bifunctional chelating agent. In this paper, we describ...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1007/s00259-008-0837-7

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
RDM
Sub department:
OCDEM
Role:
Author
Journal:
European journal of nuclear medicine and molecular imaging More from this journal
Volume:
35
Issue:
12
Pages:
2286-2293
Publication date:
2008-12-01
DOI:
EISSN:
1619-7089
ISSN:
1619-7070
Language:
English
Keywords:
Pubs id:
pubs:138672
UUID:
uuid:6c4591ac-40e6-441f-bc7f-a1e001ad0514
Local pid:
pubs:138672
Source identifiers:
138672
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP